A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval ...

Rocket Lab stock is gaining as Elon Musk stepping up his feud with President Donald Trump. Here are some other companies to watch.